![](/sites/default/files/2019-09/Prescription%2520drugs_5.jpg)
Canada’s Valeant Pharmaceuticals International has agreed to acquire Australia-based iNova, a private pharmaceutical group.
iNova owns, develops and markets a portfolio of prescription and OTC pharmaceutical products in the Asia-Pacific region and South Africa, including therapeutic weight management brands such as Duromine and OTC brands in the cold and cough market such as Difflam and Duro Tuss.